Dyneval Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: SC659307

Dyneval Limited

Filleted Unaudited Financial Statements

30 April 2025

Dyneval Limited

Statement of Financial Position

30 April 2025

	2025	2024
Note	£	£

Fixed Assets

Intangible assets	5	1,713,114	1,177,357
Tangible assets	6	26,826	51,703
		------------	------------
		1,739,940	1,229,060

Current Assets

Stocks		128,904	141,767
Debtors	7	54,787	35,650
Cash at bank and in hand		109,445	364,368
		---------	---------
		293,136	541,785

Creditors: amounts falling due within one year	8	198,217	145,913
		---------	---------
Net Current Assets		94,919	395,872
		------------	------------
Total Assets Less Current Liabilities		1,834,859	1,624,932

Creditors: amounts falling due after more than one year	9	85,014	152,158
		------------	------------
Net Assets		1,749,845	1,472,774
		------------	------------

Capital and Reserves

Called up share capital	2,813	2,493
Share premium account	2,100,658	1,638,138
Profit and loss account	( 353,626)	( 167,857)
	------------	------------
Shareholders Funds	1,749,845	1,472,774
	------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Dyneval Limited

Statement of Financial Position (continued)

30 April 2025

These financial statements were approved by the board of directors and authorised for issue on 27 October 2025 , and are signed on behalf of the board by:

Dr T Wood

Director

Company registration number: SC659307

Dyneval Limited

Notes to the Financial Statements

Year Ended 30 April 2025

1. General Information

The company is a private company limited by shares, registered in Scotland. The address of the registered office is 3rd Floor, City Point, 65 Haymarket Terrace, Edinburgh, EH12 5HD.

2. Statement of Compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting Policies

Basis of Preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Going Concern

The Directors have prepared detailed forecasts, inclusive of sensitivity analysis and as at the date of signing the accounts, the company was on track to fulfil the forecasted commercial traction. On this basis and with the ongoing support of the shareholder base, the Directors believe that the company can continue trading for a period of at least 12 months from the date of signing these financial statements and therefore the financial statements have been prepared on a going concern basis.

Judgements and Key Sources of Estimation Uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue Recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Intangible Assets

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Development costs	-	20% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Research and Development

Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.

Tangible Assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant and machinery	-	33% straight line
SaaS Units	-	33% reducing balance
Equipment	-	25% reducing balance

Impairment of Fixed Assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Financial Instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.

4. Employee Numbers

The average number of persons employed by the company during the year amounted to 14 (2024: 12 ).

5. Intangible Assets

	Development costs	Patents, trademarks and licences	Total
	£	£	£
Cost
At 1 May 2024	1,208,803	46,483	1,255,286
Additions	485,711	76,543	562,254
	------------	---------	------------
At 30 April 2025	1,694,514	123,026	1,817,540
	------------	---------	------------
Amortisation
At 1 May 2024	77,929	–	77,929
Charge for the year	26,497	–	26,497
	------------	---------	------------
At 30 April 2025	104,426	–	104,426
	------------	---------	------------
Carrying amount
At 30 April 2025	1,590,088	123,026	1,713,114
	------------	---------	------------
At 30 April 2024	1,130,874	46,483	1,177,357
	------------	---------	------------

6. Tangible Assets

	Plant and machinery	SaaS units	Equipment	Total
	£	£	£	£
Cost
At 1 May 2024 and 30 April 2025	45,356	27,625	28,715	101,696
	--------	--------	--------	---------
Depreciation
At 1 May 2024	27,911	9,425	12,657	49,993
Charge for the year	14,856	6,006	4,015	24,877
	--------	--------	--------	---------
At 30 April 2025	42,767	15,431	16,672	74,870
	--------	--------	--------	---------
Carrying amount
At 30 April 2025	2,589	12,194	12,043	26,826
	--------	--------	--------	---------
At 30 April 2024	17,445	18,200	16,058	51,703
	--------	--------	--------	---------

7. Debtors

	2025	2024
	£	£
Trade debtors	24,254	8,436
Other debtors	30,533	27,214
	--------	--------
	54,787	35,650
	--------	--------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	17,298	23,923
Social security and other taxes	14,327	8,217
Other creditors	166,592	113,773
	---------	---------
	198,217	145,913
	---------	---------

9. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Other creditors	85,014	152,158
	--------	---------

10. Directors' Advances, Credits and Guarantees

During the year the directors entered into the following advances and credits with the company:

	2025
	Balance brought forward	Advances/ (credits) to the directors	Balance outstanding
	£	£	£
Dr T Wood	( 72)	196	124
Dr V Martinez	( 455)	–	( 455)
	----	----	----
	( 527)	196	( 331)
	----	----	----

	2024
	Balance brought forward	Advances/ (credits) to the directors	Balance outstanding
	£	£	£
Dr T Wood	( 72)	–	( 72)
Dr V Martinez	( 455)	–	( 455)
	----	----	----
	( 527)	–	( 527)
	----	----	----